article · 2019
Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)
James F. Donohue, Edward Kerwin, Sanjay Sethi, Brett Haumann, Srikanth Pendyala, Lorna Dean, Chris N. Barnes, Edmund J. Moran
19 citationsRespiratory ResearchDOI: https://doi.org/10.1186/s12931-019-1187-7Open accessPDF reported by metadataFull text reported by metadata